
Cambiotics secures funding to initiate clinical trials and commercialize a dietary supplement for removing PFAS from the human body
Left to right: Peter Holme Jensen, Chief Executive Officer and Co-founder & Steen Dannemann Andersen, Chairman of the Board Copenhagen, Kingdom of Denmark – February 2nd, 2026 …





